Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis.

Epigenetic modifications, including changes in DNA methylation, lead to altered gene expression and thus may underlie epileptogenesis via induction of permanent changes in neuronal excitability. Therapies that could inhibit or reverse these changes may be highly effective in halting disease progression. Here we identify an epigenetic function of the brain's endogenous anticonvulsant adenosine, showing that this compound induces hypomethylation of DNA via biochemical interference with the transmethylation pathway. We show that inhibition of DNA methylation inhibited epileptogenesis in multiple seizure models. Using a rat model of temporal lobe epilepsy, we identified an increase in hippocampal DNA methylation, which correlates with increased DNA methyltransferase activity, disruption of adenosine homeostasis, and spontaneous recurrent seizures. Finally, we used bioengineered silk implants to deliver a defined dose of adenosine over 10 days to the brains of epileptic rats. This transient therapeutic intervention reversed the DNA hypermethylation seen in the epileptic brain, inhibited sprouting of mossy fibers in the hippocampus, and prevented the progression of epilepsy for at least 3 months. These data demonstrate that pathological changes in DNA methylation homeostasis may underlie epileptogenesis and reversal of these epigenetic changes with adenosine augmentation therapy may halt disease progression.

[1]  D. Boison.  Adenosine Kinase: Exploitation for Therapeutic Gain , 2013, Pharmacological Reviews.

[2]  F. Lubin.  Epileptogenesis: Can the Science of Epigenetics Give Us Answers? , 2012, Epilepsy currents.

[3]  B. Fredholm.  Rethinking the purinergic neuron–glia connection , 2012, Proceedings of the National Academy of Sciences.

[4]  Nita Ahuja,et al.  Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. , 2012, Cancer cell.

[5]  Wei Liu,et al.  Neuronal Adenosine Release, and Not Astrocytic Atp Release, Mediates Feedback Inhibition of Excitatory Activity. Adenosine Release during Seizures Attenuates Gabaa Receptor-mediated Depolarization. Adenosine and Seizure Termination: Endogenous Mechanisms , 2022 .

[6]  John S Duncan,et al.  The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study , 2011, The Lancet.

[7]  C. Passananti,et al.  ADP-ribose polymers localized on Ctcf–Parp1–Dnmt1 complex prevent methylation of Ctcf target sites , 2011, The Biochemical journal.

[8]  J. C. Baayen,et al.  Upregulation of adenosine kinase in astrocytes in experimental and human temporal lobe epilepsy , 2011, Epilepsia.

[9]  B. Fredholm,et al.  A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors. , 2011, The Journal of clinical investigation.

[10]  I. Blümcke,et al.  The methylation hypothesis: Do epigenetic chromatin modifications play a role in epileptogenesis? , 2011, Epilepsia.

[11]  Kevin J. Staley,et al.  The time course of acquired epilepsy: Implications for therapeutic intervention to suppress epileptogenesis , 2011, Neuroscience Letters.

[12]  D. Poulsen,et al.  Adenosine kinase determines the degree of brain injury after ischemic stroke in mice , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  A. Pitkänen,et al.  Mechanisms of epileptogenesis and potential treatment targets , 2011, The Lancet Neurology.

[14]  Wolfgang Löscher,et al.  Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research , 2010, Pharmacological Reviews.

[15]  M. Mehler,et al.  Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis , 2010, Neurobiology of Disease.

[16]  B. Fredholm,et al.  Adenosine signaling and function in glial cells , 2010, Cell Death and Differentiation.

[17]  Guoping Fan,et al.  Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons , 2010, Nature Neuroscience.

[18]  M. Szyf,et al.  Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. , 2009, Medical hypotheses.

[19]  Radhey S. Gupta,et al.  Subcellular localization of adenosine kinase in mammalian cells: The long isoform of AdK is localized in the nucleus. , 2009, Biochemical and biophysical research communications.

[20]  Eleanor M. Pritchard,et al.  Antiepileptic effects of silk-polymer based adenosine release in kindled rats , 2009, Experimental Neurology.

[21]  D. Boison.  Adenosine augmentation therapies (AATs) for epilepsy: Prospect of cell and gene therapies , 2009, Epilepsy Research.

[22]  M. Hildebrandt,et al.  Increased Reelin Promoter Methylation Is Associated With Granule Cell Dispersion in Human Temporal Lobe Epilepsy , 2009, Journal of neuropathology and experimental neurology.

[23]  G. Ming,et al.  Neuronal Activity–Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis , 2009, Science.

[24]  D. Boison.  The adenosine kinase hypothesis of epileptogenesis , 2008, Progress in Neurobiology.

[25]  Shigeyoshi Itohara,et al.  Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice. , 2008, The Journal of clinical investigation.

[26]  E. Kavalali,et al.  Activity-Dependent Suppression of Miniature Neurotransmission through the Regulation of DNA Methylation , 2008, The Journal of Neuroscience.

[27]  R. Simon,et al.  Downregulation of Hippocampal Adenosine Kinase after Focal Ischemia as Potential Endogenous Neuroprotective Mechanism , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  D. Boison.  Adenosine as a modulator of brain activity. , 2007, Drug news & perspectives.

[29]  D. Boison.  Adenosine kinase, epilepsy and stroke: mechanisms and therapies. , 2006, Trends in pharmacological sciences.

[30]  A. Marowsky,et al.  Shift of adenosine kinase expression from neurons to astrocytes during postnatal development suggests dual functionality of the enzyme , 2006, Neuroscience.

[31]  Thomas Rülicke,et al.  Astrogliosis in epilepsy leads to overexpression of adenosine kinase, resulting in seizure aggravation. , 2005, Brain : a journal of neurology.

[32]  S. Yao,et al.  The equilibrative nucleoside transporter family, SLC29 , 2004, Pflügers Archiv.

[33]  K. Giacomini,et al.  The concentrative nucleoside transporter family, SLC28 , 2004, Pflügers Archiv.

[34]  J. Fritschy,et al.  Overexpression of Adenosine Kinase in Epileptic Hippocampus Contributes to Epileptogenesis , 2022 .

[35]  R. Cunha,et al.  Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats , 2003, The European journal of neuroscience.

[36]  J. Fritschy,et al.  Seizure Suppression by Adenosine A1 Receptor Activation in a Mouse Model of Pharmacoresistant Epilepsy , 2003, Epilepsia.

[37]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[38]  I. Pogribny,et al.  Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. , 2002, The Journal of nutrition.

[39]  N. Déglon,et al.  Seizure Suppression by Adenosine‐releasing Cells Is Independent of Seizure Frequency , 2002, Epilepsia.

[40]  B. Fowler,et al.  Neonatal hepatic steatosis by disruption of the adenosine kinase gene , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Fredholm,et al.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  N. Déglon,et al.  Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Simon,et al.  Relationship Between Seizure‐Induced Transcription of the DNA Damage‐Inducible Gene GADD45, DNA Fragmentation, and Neuronal Death in Focally Evoked Limbic Epilepsy , 1999, Journal of neurochemistry.

[44]  G. Golarai,et al.  Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  David W. Martin,et al.  Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T lymphoma cells , 1977, Cell.

[46]  David L Kaplan,et al.  Silk polymer-based adenosine release: therapeutic potential for epilepsy. , 2008, Biomaterials.

[47]  F. Dudek,et al.  Epileptogenesis in the dentate gyrus: a critical perspective. , 2007, Progress in brain research.

[48]  H. Kupferberg,et al.  The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy. , 1998, Advances in neurology.